Germany · Delayed Price · Currency is EUR Evotec SE Statistics
Total Valuation
Evotec SE has a market cap or net worth of EUR 555.29 million. The enterprise value is 636.17 million.
| Market Cap | 555.29M |
| Enterprise Value | 636.17M |
Important Dates
The last earnings date was Thursday, November 5, 2026.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Evotec SE has 177.75 million shares outstanding. The number of shares has increased by 0.05% in one year.
| Current Share Class | 177.75M |
| Shares Outstanding | 177.75M |
| Shares Change (YoY) | +0.05% |
| Shares Change (QoQ) | +0.03% |
| Owned by Insiders (%) | 0.17% |
| Owned by Institutions (%) | 29.87% |
| Float | 147.03M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.78 |
| PB Ratio | 0.88 |
| P/TBV Ratio | 1.68 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.89 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.32, with a Debt / Equity ratio of 0.75.
| Current Ratio | 2.32 |
| Quick Ratio | 2.00 |
| Debt / Equity | 0.75 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -25.07% and return on invested capital (ROIC) is -18.45%.
| Return on Equity (ROE) | -25.07% |
| Return on Assets (ROA) | -4.92% |
| Return on Invested Capital (ROIC) | -18.45% |
| Return on Capital Employed (ROCE) | -10.58% |
| Weighted Average Cost of Capital (WACC) | 6.18% |
| Revenue Per Employee | 164,038 |
| Profits Per Employee | -41,266 |
| Employee Count | 4,461 |
| Asset Turnover | 0.44 |
| Inventory Turnover | 18.71 |
Taxes
In the past 12 months, Evotec SE has paid 17.85 million in taxes.
| Income Tax | 17.85M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -38.82% in the last 52 weeks. The beta is 1.31, so Evotec SE's price volatility has been higher than the market average.
| Beta (5Y) | 1.31 |
| 52-Week Price Change | -38.82% |
| 50-Day Moving Average | 2.89 |
| 200-Day Moving Average | 4.24 |
| Relative Strength Index (RSI) | 62.23 |
| Average Volume (20 Days) | 1,089,918 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Evotec SE had revenue of EUR 718.32 million and -180.71 million in losses. Loss per share was -1.02.
| Revenue | 718.32M |
| Gross Profit | 73.76M |
| Operating Income | -129.02M |
| Pretax Income | -162.86M |
| Net Income | -180.71M |
| EBITDA | -59.78M |
| EBIT | -129.02M |
| Loss Per Share | -1.02 |
Balance Sheet
The company has 400.94 million in cash and 481.81 million in debt, with a net cash position of -80.88 million or -0.46 per share.
| Cash & Cash Equivalents | 400.94M |
| Total Debt | 481.81M |
| Net Cash | -80.88M |
| Net Cash Per Share | -0.46 |
| Equity (Book Value) | 641.66M |
| Book Value Per Share | 3.61 |
| Working Capital | 377.62M |
Cash Flow
In the last 12 months, operating cash flow was -91.39 million and capital expenditures -33.86 million, giving a free cash flow of -125.24 million.
| Operating Cash Flow | -91.39M |
| Capital Expenditures | -33.86M |
| Depreciation & Amortization | 69.24M |
| Net Borrowing | -16.42M |
| Free Cash Flow | -125.24M |
| FCF Per Share | -0.70 |
Margins
Gross margin is 10.27%, with operating and profit margins of -17.96% and -25.16%.
| Gross Margin | 10.27% |
| Operating Margin | -17.96% |
| Pretax Margin | -22.67% |
| Profit Margin | -25.16% |
| EBITDA Margin | -8.32% |
| EBIT Margin | -17.96% |
| FCF Margin | n/a |
Dividends & Yields
Evotec SE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.05% |
| Shareholder Yield | -0.05% |
| Earnings Yield | -32.57% |
| FCF Yield | -22.30% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Analyst Forecast
The average price target for Evotec SE is 3.75, which is 20.04% higher than the current price. The consensus rating is "Hold".
| Price Target | 3.75 |
| Price Target Difference | 20.04% |
| Analyst Consensus | Hold |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | -0.91% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
The last stock split was on August 18, 2000. It was a forward split with a ratio of 2.
| Last Split Date | Aug 18, 2000 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Evotec SE has an Altman Z-Score of 0.21 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.21 |
| Piotroski F-Score | 3 |